docetaxel "ebewe" concentrate for soln for inf 10mg/ml (8ml vial)
ebewe pharma gmbh nfg. kg mondseestrasse 11, 4866 unterach, austria - docetaxel - concentrate for solution for infusion - docetaxel 10 mg/ml - antineoplastic agents
docetaxel "ebewe" concentrate for soln for inf 10mg/ml (16ml vial)
ebewe pharma gmbh nfg. kg mondseestrasse 11, 4866 unterach, austria - docetaxel - concentrate for solution for infusion - docetaxel 10 mg/ml - antineoplastic agents
gemcitabine ebewe 10 mg/ml concentrate for solution for infusion
ebewe pharma ges.m.b.h nfg. kg - gemcitabin hcl gemcitabin hcl gemcitabin hcl - concentrate for soln for inf - 10
carboplatin ebewe concentrate for solution for infusion
ebewe pharma ges. m.b.h. nfg. kg - carboplatin - concentrate for solution for infusion - 10mg/ml
cisplatin ebewe
novartis new zealand ltd - cisplatin 1 mg/ml - solution for injection - 1 mg/ml - active: cisplatin 1 mg/ml excipient: hydrochloric acid sodium chloride water for injection - cisplatin ebewe is indicated as palliative therapy to be employed as follows: metastatic non-seminomatous germ cell carcinoma: in established combination therapy with other approved chemotherapeutic agents in patients with metastatic non-seminomatous germ cell tumours who have already received appropriate surgical and/or radiotherapeutic procedures. metastatic ovarian tumours: cisplatin ebewe, as a single agent, is indicated as secondary therapy in patients with metastatic ovarian tumours refractory to standard chemotherapy who have not previously received cisplatin ebewe therapy. advanced and refractory carcinoma of the bladder: cisplatin ebewe, as a single agent, is indicated as secondary therapy in patients with advanced stage bladder cancer refractory to standard chemotherapy who have not previously received cisplatin ebewe therapy. squamous cell carcinoma of the head and neck (refractory to standard chemotherapy): cisplatin ebewe, as a single agent, is indicated as secondary therapy in patients with squamous cell carcinoma of the head and neck refractory to standard chemotherapy who have not previously received cisplatin ebewe therapy.
carboplatin "ebewe" 10 mg/ml concentrate for soln for inf
ebewe pharma ges.m.b.h nfg. kg - carboplatin - concentrate for soln for inf - 10 mg/ml
gemcitabine ebewe 10 mg/ml concentrate for solutio 10 micromol concentrate for soln for inf
ebewe pharma ges.m.b.h nfg. kg - gemcitabin hcl gemcitabin hcl gemcitabin hcl - concentrate for soln for inf - 10 micromol
vinorelbine ebewe 10 mg/ml concentrate for soln for inf
fannin limited - vinorelbine - concentrate for soln for inf - 10 mg/ml - vinca alkaloids and analogues
cisplatin 10mg/10ml concentrate for solution for infusion vials
sandoz ltd - cisplatin - solution for infusion - 1mg/1ml
cisplatin 'ebewe'
ebewe pharma ges.m.b.h nfg. kg - cisplatin - concentrate for soln for inf - 0.5